Global Digital PCR Market Growth (Status and Outlook) 2023-2029

Global Digital PCR Market Growth (Status and Outlook) 2023-2029

Digital PCR (Digital PCR-dPCR) technology is a new method for nucleic acid detection and quantification. Unlike traditional quantitative PCR (qPCR) technology, digital PCR uses absolute quantification and does not rely on standard curves and reference samples to directly detect targets The copy number of the sequence. Because this detection method has better sensitivity, specificity and accuracy than traditional qPCR, dPCR has been widely used quickly. This technology is used in the detection of very small amounts of nucleic acid samples, detection of rare mutations in complex backgrounds and identification of small differences in expression levels. The realized advantages have been widely recognized, and its many advantages in gene expression research, microRNA research, genome copy number identification, rare mutation detection of cancer markers, identification of pathogenic microorganisms, identification of transgenic components, accurate quantification of NGS sequencing libraries, and result verification, etc. The broad application prospects it has already received more and more attention.

LPI (LP Information)' newest research report, the “Digital PCR Industry Forecast” looks at past sales and reviews total world Digital PCR sales in 2022, providing a comprehensive analysis by region and market sector of projected Digital PCR sales for 2023 through 2029. With Digital PCR sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital PCR industry.

This Insight Report provides a comprehensive analysis of the global Digital PCR landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Digital PCR portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital PCR market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital PCR and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital PCR.

The global Digital PCR market size is projected to grow from US$ 2996.7 million in 2022 to US$ 3610.3 million in 2029; it is expected to grow at a CAGR of 2.7% from 2023 to 2029.

During the forecast period, the Asia-Pacific region (including China, India, Japan and other regions in the Asia-Pacific region) will develop at a faster growth rate. As global life sciences companies have increased their focus on this region, and this booming development has increased awareness about the diagnosis and treatment of genetic-based diseases, more and more public and private funds are supporting the development of new dPCR technology, Indian Genome. The academic market is rising, and factors such as the continued strengthening of Japanese cancer research have contributed to the rapid development of the Asia-Pacific market. Due to the significant growth opportunities offered by emerging countries, some related companies have begun to focus on expanding their product distribution networks in these emerging markets.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital PCR market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Microreactor/Orifice Plate Digital PCR
Microfluidic Chip Digital PCR
Droplet Digital PCR

Segmentation by application
Early Study of Tumor
Quantitative Analysis of A New Generation Sequencing Library
Gene Expression Analysis
Pathogen Detection
Prenatal Diagnosis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffman-LA Roche Ltd.
Qiagen N.V.
Agilent Technologies, Inc.
Takara Bio, Inc.
Biomérieux S.A.
Affymetrix, Inc.
Fluidigm Corporation
Raindance Technologies, Inc

Please note: The report will take approximately 2 business days to prepare and deliver.